← catalyst
CMPS
1 catalyst · 0 upcoming · 0 awaiting · 1 resolved
Resolved
all
fda
[FDA]
·
Aug 9, 2024
→ UNFAVORABLE
Midomafetamine (MDMA) NDA — PTSD adjunct therapy
▸ analysis · bull/bear · base rate —
pro
CMPS
ATAI
MNMD
CYBN
GHRS